Canada is experiencing an acute shortage of nitroglycerin, forcing emergency measures. But with drug manufacturing being international, will it be the only country to suffer?
Patients with coronary artery disease in Canada have been facing months of shortages of the nitroglycerin drugs used to treat angina pain, forcing government regulators to extend the expiry dates on some products to stretch supplies further. Read more in the BMJ.